Overview
Psychostimulants are a class of pharmaceutical agents that act on the central nervous system to enhance cognitive functioning, increase energy, and promote feelings of alertness and wakefulness. They are commonly used to treat a variety of conditions, including attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. The main neurotransmitters that are affected by psychostimulants are dopamine and norepinephrine, which play a key role in regulating mood, attention, and motivation. By increasing the availability of these neurotransmitters in the brain, psychostimulants can enhance mental clarity and focus, increase energy levels, and promote a sense of well-being. Among the most common psychostimulant drugs are methylphenidate (Ritalin), dextroamphetamine (Dexedrine), and Adderall. These medications are often prescribed to children and adults with ADHD, as they can improve attention and reduce hyperactivity and impulsivity. They can also boost academic and occupational performance, making them popular among students and professionals. Even though psychostimulants can be highly effective in treating certain conditions, they are associated with a range of side effects, including insomnia, loss of appetite, headache, irritability, and anxiety. Long-term use of psychostimulants may also lead to tolerance and addiction, so it is important to use them under the guidance of a medical professional and to be aware of their potential risks. In conclusion, psychostimulants are a powerful class of drugs that have revolutionized the treatment of ADHD and other conditions. While they have their benefits, they should be used judiciously and with caution to avoid unwanted side effects and the risk of addiction.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.
How this research is being cited
The 1 article above has been cited 13 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Nikiwe Mpisane et al. · 2025 · Journal of Research in Special Educational Needs
-
2025 · Journal of Research in Special Educational Needs
-
Maren Helene Rinke Storetvedt et al. · 2024 · Frontiers Digit. Health
-
2024 · Frontiers in Digital Health
-
2023 · Journal of Infant Child and Adolescent Psychotherapy
-
Csilla Ágoston et al. · 2022 · Frontiers in Psychiatry
-
2022 · Frontiers in Psychiatry
-
2021 · Support for Learning
A sample of recent works citing this journal's research on Psychostimulants, linking to each citing work.